Surge In Applications Triggers User Fee Inflation
Executive Summary
With full NDA and BLA submissions to FDA now growing faster than INDs and supplements, user fees are increasing more rapidly as well.
You may also be interested in...
What Goes Up … US FDA Expects 2016 NME Approval Total To Come Down
After a record-setting 2015 for new drug approvals, there were not enough applications with user fee goals in 2016 to reach that level again.
PDUFA Fees Forced Down For FY 2017 Due To Refund Provision
Final year of this user fee cycle will include 14% discount, but agency says it is ready for revenue reduction.
PDUFA Fees Forced Down For FY 2017 Due To Refund Provision
Final year of this user fee cycle will include 14% discount, but agency says it is ready for revenue reduction.